Paloma Partners’s Endologix Inc ELGX Stock Holding History

Paloma Partners’s Portfolio ELGX Stock Details ELGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-37,100	Closed	-$269K	–	2463
2019 Q2	$269K	Buy	+37,100	New	+$253K	﹤0.01%	1362
2018 Q4	–	Sell	-9,650	Closed	-$184K	–	1972
2018 Q3	$184K	Buy	+9,650	New	+$344K	﹤0.01%	1414
2015 Q3	–	Sell	-1,289	Closed	-$197K	–	2108
2015 Q2	$197K	Buy	+1,289	New	+$213K	﹤0.01%	1570

Other funds holding ELGX

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Paloma Partners's ELGX Position: Q3 2019 in Review

Paloma Partners sold out of Endologix Inc (ELGX) in Q3 2019, closing a stake of 37,100 shares — an estimated $269K sold.

Paloma Partners first reported a position in ELGX in Q2 2015 and held it in 3 quarters. The position peaked at $269K in Q2 2019. 63 funds tracked by Wall St. Rank hold ELGX as of Q3 2019.

Paloma Partners reported no remaining Endologix Inc position as of Q3 2019 after selling out during the quarter.
Paloma Partners sold 37,100 Endologix Inc shares in Q3 2019, an estimated $269K.
Paloma Partners first reported a position in Endologix Inc in Q2 2015 and held it in 3 quarters.
Paloma Partners's Endologix Inc position peaked at $269K in Q2 2019.
63 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2019.

Based on Paloma Partners's 13F filing for Q3 2019, filed 14 Nov 2019.